Arixtra subcutaneous injection 5mg, manufactured by Sand Pharma, contains Fondaparinux sodium, a selective factor Xa inhibitor used to prevent and treat blood clots, including deep vein thrombosis and pulmonary embolism. This injectable drug has a YJ code of 3339400G3021 and a standard of 5 mg in 0.4 mL per tube.
Arixtra subcutaneous injection 5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →